Boston Partners Sells 66,100 Shares of Clarivate Plc (NYSE:CLVT)

Boston Partners lowered its position in Clarivate Plc (NYSE:CLVT - Free Report) by 1.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,367,351 shares of the company's stock after selling 66,100 shares during the period. Boston Partners owned about 0.61% of Clarivate worth $22,197,000 as of its most recent SEC filing.

Other hedge funds have also added to or reduced their stakes in the company. KBC Group NV raised its holdings in Clarivate by 33.2% during the 3rd quarter. KBC Group NV now owns 10,225 shares of the company's stock worth $73,000 after buying an additional 2,549 shares during the period. Empowered Funds LLC acquired a new stake in shares of Clarivate during the third quarter worth $101,000. Integrated Investment Consultants LLC lifted its position in Clarivate by 2.9% in the 3rd quarter. Integrated Investment Consultants LLC now owns 96,656 shares of the company's stock valued at $686,000 after acquiring an additional 2,696 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its stake in Clarivate by 0.8% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 4,604,449 shares of the company's stock worth $32,692,000 after purchasing an additional 38,355 shares during the period. Finally, Cerity Partners LLC increased its holdings in Clarivate by 82.5% during the 3rd quarter. Cerity Partners LLC now owns 202,204 shares of the company's stock worth $1,436,000 after purchasing an additional 91,384 shares in the last quarter. Institutional investors and hedge funds own 85.72% of the company's stock.

Clarivate Stock Down 1.2 %

Shares of NYSE CLVT traded down $0.05 during midday trading on Tuesday, reaching $4.09. The company's stock had a trading volume of 5,007,046 shares, compared to its average volume of 4,818,557. The stock has a 50 day simple moving average of $4.77 and a 200-day simple moving average of $5.48. The company has a current ratio of 0.87, a quick ratio of 0.88 and a debt-to-equity ratio of 0.88. The stock has a market capitalization of $2.82 billion, a price-to-earnings ratio of -4.26 and a beta of 1.28. Clarivate Plc has a fifty-two week low of $3.96 and a fifty-two week high of $7.77.

Remove Ads

Clarivate announced that its Board of Directors has approved a stock repurchase program on Monday, December 16th that allows the company to buyback $500.00 million in outstanding shares. This buyback authorization allows the company to repurchase up to 12.8% of its shares through open market purchases. Shares buyback programs are generally a sign that the company's board of directors believes its stock is undervalued.

Analyst Upgrades and Downgrades

Separately, Royal Bank of Canada restated a "sector perform" rating and issued a $6.00 price target on shares of Clarivate in a report on Thursday, February 20th.

Clarivate Company Profile

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.